Cargando...
Genome-Scale Metabolic Modeling of Glioblastoma Reveals Promising Targets for Drug Development
Glioblastoma (GBM) is an aggressive type of brain cancer with a poor prognosis for affected patients. The current line of treatment only gives the patients a survival time of on average 15 months. In this work, we use genome-scale metabolic models (GEMs) together with other systems biology tools to...
Gardado en:
| Publicado en: | Front Genet |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7181968/ https://ncbi.nlm.nih.gov/pubmed/32362913 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fgene.2020.00381 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|